STEPHEN YENZEN LAI to Methylenetetrahydrofolate Reductase (NADPH2)
This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Methylenetetrahydrofolate Reductase (NADPH2).
Connection Strength
0.024
-
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer. Ann Oncol. 2011 Nov; 22(11):2482-2488.
Score: 0.024
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.